Puma Biotechnology (PBYI) Gross Margin Growth (3y) (2020 - 2026)

Puma Biotechnology (PBYI) Gross Margin Growth (3y) (2020 - 2026) Analysis & Trends

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin Growth (3y) (Qtr)
1 Oculis Holding AG 68,785.72 Bn 68,785.72 Bn - -
2 Nanobiotix 1,895.57 Bn 1,895.51 Bn - -
3 BeOne Medicines 471.35 Bn 466.56 Bn 1.35 Bn 722.00
4 NuCana 279.75 Bn 279.75 Bn - -
5 Vertex Pharmaceuticals 120.24 Bn 113.00 Bn 2.59 Bn -191.00
6 Regeneron Pharmaceuticals 67.80 Bn 59.04 Bn 3.31 Bn -162.00
7 Belite Bio 62.51 Bn 62.51 Bn - -
8 Argenx Se 57.38 Bn 57.38 Bn 1.41 Bn -40.00
9 Revolution Medicines 37.78 Bn 37.78 Bn - -
10 Puma Biotechnology 407.27 Mn 368.99 Mn 34.39 Mn 179.00

Historic Data

Download Data
DateValue
Mar 31, 2026 179.00
Dec 31, 2025 -1,144.00
Sep 30, 2025 -46.00
Jun 30, 2025 161.00
Mar 31, 2025 77.00
Dec 31, 2024 -208.00
Sep 30, 2024 -1,390.00
Jun 30, 2024 -22.00
Mar 31, 2024 560.00
Dec 31, 2023 -1,288.00
Sep 30, 2023 -408.00
Jun 30, 2023 -839.00
Mar 31, 2023 -733.00
Dec 31, 2022 -309.00
Sep 30, 2022 -525.00
Jun 30, 2022 -779.00
Mar 31, 2022 -1,565.00
Dec 31, 2021 -691.00
Sep 30, 2021 -778.00
Jun 30, 2021 -503.00